Sean im not coming at you, I’m coming at your idea. I’ve been through this so many times over the last couple decades and piecemeal a drug to sell often an indication just to get revenue is Ludacris. Keep it all in one place and let first right of refusal play out. It’s not going to be a small cap or a medium cap biotech. It’s going to be one of the big dogs. And we don’t know who that is because we know at ESMOJ and company talked to all of the big dogs. Those who have PD interests and current or future products and those who might want to get in that space. There’s Jacqui and going on right now. 100%. They are all pitching back to CYDY after the companies initial pitch which was the poster. Sure confirmatory trials might need to happen and that’s OK especially because we have CRC to further confirm.

But suggesting that there is a spin off to gates doesn’t help our cause. It only allows people who don’t know the process to think that might be an option and then we go down other rabbit holes so I’d rather just let that rumor die here tonight. Like I said that’s not the way this works. Yahoo thinks it does so let yahoo think that way.